Institutional Career Development Core

机构职业发展核心

• 批准号: 10349634
• 负责人: Sarah Jane Schlesinger
• 金额: $ 89.6万
• 依托单位: ROCKEFELLER UNIVERSITY
• 依托单位国家: 美国
• 财政年份: 2016
• 资助国家: 美国
• 起止时间: 2016-07-05 至 2026-05-31
• 项目状态: 未结题
• 来源: https://reporter.nih.gov/project-details/10349634
• 关键词: Adherence; Bioinformatics; Biometry; Career Choice; Clinical; Clinical Research; Clinical Sciences; Communities; Competence; Complement; Conceptions; Degree program; Electronics; Epidemiology; Feedback; Formulation; Goals; Grant; Health; Health Professional; Health Status; Human; Humanities; Instruction; Lead; Leadership; Master' s Degree; Mentors; Methods; Modeling; Ontology; Participant; Pharmacologic Substance; Phenotype; Physicians; Policies; Privatization; Production; Protocols documentation; Reporting; Reproducibility; Research; Resources; Science; Scientist; Special Event; Training; Translational Research; Translations; United States National Academy of Sciences; Universities; Vision; career; career development; clinical center; didactic education; experience; health record; improved; innovation; meetings; member; new technology; programs; responsible research conduct; translational scientist

The overall vision of the Rockefeller University Center for Clinical and Translational Science (CCTS), supported by the CTSA program, is to develop, demonstrate, and disseminate innovative programs so as to create a model clinical research enterprise built on rigor, responsible and transparent reporting, and scientific integrity to empower translation of paradigm-breaking discoveries into better human health. The overarching goal of our KL2 Clinical Scholars Master's degree program is to prepare our trainees to be successful, scientifically independent, translational investigators who can lead translational teams on projects to improve human health. The core of the program is a mentored translational research experience in which the Scholar serves as a translational team science leader, and develops, conducts, analyzes, and disseminates the results of a human participant study under the guidance of a distinguished senior scientific mentor and with the assistance of a cadre of Translational Science Team Experts/Educators. This experience is complemented by a didactic curriculum including tutorials in Clinical and Translational Science, Biostatistics, Bioinformatics, and Epidemiology; a weekly Clinical Research Seminar by outstanding translational investigators; a private weekly meeting with the seminar speaker; team science leadership training; a graduate level scientific course; Humanities and Translational Science special events; and training in the Responsible Conduct of Research. Our program benefits from the scientific strength of the mentors in the program, with 10 of the mentors of Scholars during the current grant period being elected members of the National Academy of Sciences. Thus, our specific aims are: 1. To train physician scientists and doctoral level health professionals as outstanding, scientifically independent translational investigators in a 3 year mentored KL2 Clinical Scholars Master's degree program that includes: a) leadership of a human participant protocol from conception to reporting, b) a didactic curriculum to help the Scholar master the competencies to function as a rigorous independent translational scientist, c) focused instruction and feedback to develop the team science leadership competencies required to successfully lead a translational science team. 2. To introduce new educational programs to maximize Scholars' educational experience and ability to consider a wide variety of career choices, as well as benefit from emerging new technology and resources: a) Team science leadership training, b) Pharmaceutical production and formulation, d) Ontology-driven human phenotyping, e) Searching Electronics Health Records and causal inference, e) From discovery to health-enhancing product, and f) Engaging communities as full partners. 3. Reinforce the importance of achieving the highest possible levels of rigor, reproducibility, and reporting (R3) and assist Scholars in developing best practices early in their research careers so that they can incorporate new methods and policies to constantly improve their adherence to evolving standards.

洛克菲勒大学临床和翻译科学中心(CCTS)的总体愿景，支持 通过CTSA计划，是为了开发、示范和传播创新计划，从而创建一个典范 临床研究企业建立在严谨、负责和透明的报告以及科学诚信的基础上 将突破范式的发现转化为更好的人类健康。我们的首要目标是 KL2临床学者硕士学位课程是为我们的实习生做好科学上的成功准备 独立的翻译调查人员，可以领导翻译团队开展改善人类健康的项目。 该计划的核心是一次有指导的翻译研究经验，在该经验中，学者担任 翻译团队科学领袖，并开发、引导、分析和传播人类的结果 在杰出的高级科学导师的指导下和在 翻译科学团队专家/教育工作者的骨干。这一经历还得到了说教的补充 课程包括临床和转化科学、生物统计学、生物信息学和 流行病学；由杰出的翻译研究人员举办的每周临床研究研讨会；私人周刊 与研讨会发言人会面；团队科学领导力培训；研究生水平的科学课程； 人文科学和翻译科学特别活动；负责任的研究行为培训。我们的 该计划得益于计划中导师的科学实力，其中有10位学者导师 在本授权期内当选为美国国家科学院院士。因此，我们的具体情况 目标是：1.把内科科学家和博士级卫生专业人员培养成杰出的、科学的 三年制KL2临床学者硕士学位项目的独立翻译研究人员 包括：a)从受孕到报告的人类参与者协议的领导，b)教学课程，以 帮助学者掌握作为一名严格的独立翻译科学家的能力，c) 有重点的指导和反馈，以发展成功所需的团队科学领导能力 领导一个翻译科学团队。2.推出新的教育计划，最大限度地提高学者的教育水平 具备考虑各种职业选择的经验和能力，并能从不断涌现的新职业中获益 技术和资源：a)团队科学领导培训，b)药物生产和配方， D)本体论驱动的人类表型，e)搜索电子健康记录和因果推断，e)来自 从发现到增强健康的产品，以及f)让社区成为全面的合作伙伴。3.加强 实现尽可能高水平的严密性、可重复性和报告(R3)和辅助的重要性 学者在他们的研究生涯早期开发最佳实践，以便他们可以采用新的方法 以及不断提高对不断发展的标准的遵守程度的政策。